Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
RXST | US
1.34
2.82%
Healthcare
Medical Devices
30/06/2024
04/10/2024
48.90
48.65
49.33
47.39
RxSight Inc. an ophthalmic medical device company engages in the research and development manufacture and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight light delivery device an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. It primarily serves cataract doctors. The company was formerly known as Calhoun Vision Inc. and changed its name to RxSight Inc. in February 2017. RxSight Inc. was incorporated in 1997 and is headquartered in Aliso Viejo California.
View LessStrength based on increasing price with high volume
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Strong Revenue Growth (> 10%)
Strong Sharpe Ratio (> 1.2)
Price Below SMA10D
Smallcap (300M - 2B USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
41.5%1 month
33.1%3 months
57.5%6 months
52.2%-
105.26
7.00
0.04
0.04
-7.70
14.80
-
-38.31M
1.94B
1.94B
-
-23.89
-
67.60
-17.01
5.73
6.08
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
7.14
Range1M
11.01
Range3M
20.68
Rel. volume
1.02
Price X volume
22.86M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
LeMaitre Vascular Inc | LMAT | Medical Instruments & Supplies | 91.62 | 2.06B | 0.67% | 54.92 | 5.76% |
CONMED Corporation | CNMD | Medical Devices | 66.59 | 2.05B | -1.25% | 23.81 | 109.53% |
iRhythm Technologies Inc | IRTC | Medical Instruments & Supplies | 62.71 | 1.96B | -11.71% | n/a | 742.57% |
Warby Parker Inc. | WRBY | Medical Instruments & Supplies | 16.1 | 1.93B | 7.05% | n/a | 58.36% |
STAAR Surgical Company | STAA | Medical Instruments & Supplies | 35.07 | 1.73B | -1.71% | 112.82 | 8.87% |
AdaptHealth Corp | AHCO | Medical Devices | 10.44 | 1.40B | -3.51% | n/a | 150.02% |
AtriCure Inc | ATRC | Medical Instruments & Supplies | 27.63 | 1.35B | -0.25% | n/a | 16.30% |
Integra LifeSciences Holdings Corporation | IART | Medical Devices | 17 | 1.32B | -1.85% | 61.62 | 130.98% |
Establishment Labs Holdings Inc | ESTA | Medical Devices | 45.25 | 1.26B | 1.32% | n/a | 438.84% |
INMODE LTD. | INMD | Medical Devices | 15.78 | 1.20B | 2.20% | 10.08 | 0.00% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Kennedy-Wilson Holdings Inc | KW | Real Estate Services | 10.87 | 1.49B | -1.09% | n/a | 304.03% |
Steelcase Inc | SCS | Building Products & Equipment | 12.97 | 1.47B | 0.78% | 12.50 | 65.47% |
Marcus & Millichap Inc | MMI | Real Estate Services | 36.79 | 1.44B | -5.16% | n/a | 14.11% |
Janus International Group Inc. | JBI | Building Products & Equipment | 9.79 | 1.42B | 2.73% | 11.54 | 116.21% |
OpenTable Inc | OPEN | Real Estate Services | 1.99 | 1.40B | 4.74% | n/a | 290.30% |
Redfin Corporation | RDFN | Real Estate Services | 11.11 | 1.35B | -5.12% | n/a | -8279.77% |
Pitney Bowes Inc | PBI | Building Products & Equipment | 6.92 | 1.24B | 1.91% | n/a | -571.93% |
ARLO TECHNOLOGIES INC | ARLO | Building Products & Equipment | 11.47 | 1.15B | 0.09% | n/a | 19.46% |
The Real Brokerage Inc. Common Shares | REAX | Real Estate Services | 5.75 | 1.12B | 1.23% | n/a | 0.00% |
Latham Group Inc. | SWIM | Building Products & Equipment | 6.64 | 767.43M | 0.00% | 61.27 | 77.00% |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | -7.70 | 45.99 | Cheaper |
Ent. to Revenue | 14.80 | 13.20 | Par |
PE Ratio | - | 29.98 | - |
Price to Book | 7.00 | 6.06 | Par |
Dividend Yield | - | 1.65 | - |
Std. Deviation (3M) | 57.46 | 66.08 | Par |
Debt to Equity | 0.04 | 0.83 | Cheaper |
Debt to Assets | 0.04 | 0.28 | Cheaper |
Market Cap | 1.94B | 9.42B | Emerging |